Etienne D. M.
- Country
- France
- Department
- Intensive Care Unit
Research Overview
- Comparison of Early versus Delayed Etoposide Initiation Strategies in Critically Ill Patients with Severe Sporadic Hemophagocytic Lymphohistiocytosis: A Randomized Trial
- Comparison of Early Versus Delayed Etoposide Initiation in Severe Sporadic Hemophagocytic Lymphohistiocytosis in Intensive Care: A Randomized Trial
Data & Insights
Has run more than one trial at 15 of 15 partner sites.
Specializations
Critical Care Medicine
The investigator specializes in managing severe cases of hemophagocytic lymphohistiocytosis (HLH) in intensive care settings, with particular emphasis on treatment timing and optimization strategies.
- Intensive Care Management
- Critical Illness Interventions
- Organ Failure Treatment
Their work focuses on developing precise therapeutic timing protocols for critically ill patients.
Hematological Disorders
The investigator concentrates on the treatment of severe sporadic hemophagocytic lymphohistiocytosis, exploring innovative therapeutic approaches using etoposide administration strategies.
- Immunological Disorders
- Hematologic Emergencies
- Treatment Optimization
Their expertise extends to timing-based therapeutic interventions in complex hematological conditions.
Treatment Strategy Development
The investigator evaluates distinct therapeutic timing approaches, comparing early versus delayed intervention strategies in the treatment of severe medical conditions.
- Therapeutic Timing Protocols
- Clinical Decision Making
- Treatment Response Assessment
Their research encompasses the evaluation of treatment timing impact on patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.